Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
Association of Postural Sway with Disability Status and Cerebellar Dysfunction in People with Multiple Sclerosis: A Preliminary Study.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
CNS neuroimmunology seen by a neuropathologist.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Myeloid cells as target of fingolimod action in multiple sclerosis.
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes.
Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience.
Bilateral optic neuritis after inactivated influenza vaccination.
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
Polarization of macrophages and microglia in inflammatory demyelination.
Determination of nitrite and nitrate in cerebrospinal fluid by microchip electrophoresis with microsolid phase extraction pre-treatment.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »